Related Experiment Video
Updated: Aug 14, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Multiple sclerosis mortality and patterns of comorbidity in the United States from 1990 to 2001
Matthew D Redelings1, Lucie McCoy, Frank Sorvillo
1Los Angeles County Department of Health Services, School of Public Health, University of California at Los Angeles, Los Angeles, CA , USA. mredelings@ladhs.org
Abstract:
Multiple sclerosis (MS) is a neurodegenerative condition that can result in cognitive and physical disability and shortened life expectancy. However, population-based information is lacking regarding the mortality burden from MS in the United States. We investigated trends in MS mortality rates and examined important comorbidities in the United States from 1990 to 2001. MS deaths were matched by age, sex, and race/ethnicity with randomly selected deaths from other conditions for matched odds ratio comparisons. The overall age-adjusted mortality rate from MS was 1.44/100,000 population. MS mortality rates increased throughout the study period. MS mortality rates were higher in whites than in any other racial/ethnic group, followed by Blacks, Hispanics, American Indians/Alaska Natives, and Asians and Pacific Islanders. Observed mortality rates were more than 10 times lower in Asians and Pacific Islanders than in whites. The odds of pressure ulcers, urinary tract infections, and pneumonia/influenza being reported on the death certificate were higher in MS deaths than in matched controls.
Insights
Multiple sclerosis mortality rates in the US increased from 1990-2001. This neurodegenerative disease showed higher mortality in White populations and was linked to pressure ulcers, UTIs, and pneumonia.
Area of Science:
- Neurology
- Epidemiology
- Public Health
Background:
- Multiple sclerosis (MS) is a debilitating neurodegenerative disease impacting cognitive and physical function, and life expectancy.
- Population-based data on the mortality burden of MS in the United States is limited.
- Understanding MS mortality trends and associated comorbidities is crucial for public health initiatives.
Purpose of the Study:
- To investigate trends in multiple sclerosis mortality rates in the US from 1990 to 2001.
- To examine key comorbidities associated with MS mortality during the study period.
- To provide population-based insights into the mortality burden of MS.
Main Methods:
- Analysis of age-adjusted mortality rates for multiple sclerosis in the US population.
- Matched odds ratio comparisons using randomly selected deaths from other conditions.
- Examination of comorbidities (pressure ulcers, UTIs, pneumonia/influenza) on death certificates.
Main Results:
- The overall age-adjusted MS mortality rate was 1.44 per 100,000 population.
- MS mortality rates demonstrated an increasing trend throughout the 1990-2001 study period.
- Mortality rates were highest in White individuals, followed by Black, Hispanic, American Indian/Alaska Native, and Asian/Pacific Islander populations, with over a tenfold difference between White and Asian/Pacific Islander groups.
- Comorbidities like pressure ulcers, urinary tract infections, and pneumonia/influenza were significantly more likely to be reported in MS deaths.
Conclusions:
- Multiple sclerosis mortality rates in the US have been increasing.
- Significant racial and ethnic disparities exist in MS mortality.
- Certain comorbidities are strongly associated with increased mortality risk in individuals with MS.
Related Concept Videos
Multiple Sclerosis l: Introduction
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Factors Affecting Illness
For instance, risk factors are connected to illness, disability,...
Diagnostic and Statistical Manual of Mental Disorders (DSM)